西瓜含有JmjC结构域的组蛋白去甲基化酶家族的生物信息学分析

利用生物信息学方法,对西瓜（Citrullus lanatus（Thunb.）Matsum.&Nakai）JmjC基因家族的成员进行鉴定,对该基因家族的染色体定位、基因结构、蛋白结构域、选择压力和酶活位点进行分析,并对该基因家族与其它物种的系统进化及共线性关系进行研究。结果显示：西瓜全基因组含有17个JmjC候选基因,核苷酸序列长度为1209~5541 bp;这些基因均含有JmjC结构域,分别位于9条染色体上,归属8个亚族。系统进化、选择压力以及共线性分析结果表明,西瓜与黄瓜（Cucumis sativus L.）亲缘关系较近,JmjC家族基因数量相同,其中14个成员呈现一对一的共线性关系;而西瓜与拟南芥（Arabidopsis thaliana（L.）Heynh）亲缘关系较远,但西瓜和拟南芥同一亚族中JmjC基因间K_a/K_s的比值均小于1,推测西瓜各个亚族成员的编码蛋白功能与同一亚族的拟南芥成员功能极为相似。酶活位点分析结果表明西瓜JmjC基因家族中有10个成员具有潜在的组蛋白去甲基化酶活性。     

Oxidative DNA and RNA damage and their prognostic values during Salmonella enteritidis-induced intestinal infection in rats

Abstract

Emerging evidence suggests that microbial pathogens may induce oxidative stress in infected hosts. The aim of the present study was to investigate the relationship between changes in oxidative stress and intestinal infection with and without antibiotic treatment in animal models. Sprague-Dawley (SD) rats were divided into three groups: rats infected with Salmonella enterica serovar Enteritidis (S. enteritidis), rats infected with S. enteritidis followed by norfloxacin treatment, and the control group. To evaluate oxidative stress changes, levels of 8-oxo-7,8-dihydroguanosine (8-oxo-Gsn) and 8-oxo-7,8-dihydro-2-deoxyguanosine (8-oxo-dGsn), which represented oxidative damage to RNA and DNA, respectively, were analysed in urine and tissue samples. In urine, the level of 8-oxo-Gsn increased significantly after oral exposure to S. enteritidis (p?≤?0.001) and returned to baseline after recovery. Notably, norfloxacin treatment decreased the level of 8-oxo-Gsn in urine significantly (p?=?0.001). Changes of 8-oxo-Gsn measured in tissues from the small intestine, colon, liver and spleen were consistent with 8-oxo-Gsn measured in urine. Our study suggested that 8-oxo-Gsn in urine may serve as a highly sensitive biomarker for evaluating the severity of S. enteritidis infection and the effectiveness of antibiotic treatment against infection.     

The Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti-EGFR Monoclonal Antibodies: A Meta-Analysis

Background

BRAF mutation has been investigated as a prognostic factor in metastatic colorectal cancer (mCRC) undergoing anti-EGFR monoclonal antibodies (moAbs), but current results are still inconclusive. The aim of this meta-analysis was to evaluate the relationship between BRAF mutation status and the prognosis of mCRC patients treated with moAbs.

Methods

Eligible studies were identified by systematically searching Pubmed, the Cochrane Library, Web of Knowledge, and OVID. Risk ratio (RR) for overall response rate (ORR), Hazard ratios (HRs) for Progression free survival (PFS) and Overall survival (OS) were extracted or calculated. Prespecified subgroup analyses were conducted in KRAS wild-type and in different study types. The source of between-trial variation was explored by sensitivity analyses. Quality assessment was conducted by the Hayden’s criteria.

Results

A total of twenty one trials including 5229 patients were identified for the meta-analysis. 343 patients displayed BRAF mutations of 4616 (7.4%) patients with known BRAF status. Patients with BRAF wild-type (WT) showed decreased risks of progression and death with an improved PFS(HR 0.38, 95% confidence intervals 0.29–0.51) and an improved OS (HR 0.35 [0.29–0.42]), compared to BRAF mutant. In KRAS WT population, there were even larger PFS benefit (HR 0.29[0.19,0.43]) and larger OS benefit (HR 0.26 [0.20,0.35]) in BRAF WT. A response benefit for BRAF WT was observed (RR 0.31[0.18,0.53]) in KRAS WT patients, but not observed in unselected patients (RR 0.76 [0.43–1.33]). The results were consistent in the subgroup analysis of different study types. Heterogeneity between trials decreased in the subgroup and explained by sensitivity analysis. No publication bias of ORR, PFS and OS were detected.

Conclusions

The results indicate that BRAF mutant is a predictive biomarker for poor prognosis in mCRC patients undergoing anti-EGFR MoAbs therapy, especially in KRAS WT patients. Additional large prospective trials are required to confirm the predictive role of BRAF status.     

苦瓜叶片结构与白粉病抗性的关系

以不同抗白粉病的苦瓜品系幼苗为材料,对它们的叶片及上下表皮厚度、栅栏组织及海绵组织厚度、叶片结构紧密度及疏松度、蜡质含量、比叶重、气孔及茸毛密度等叶片结构进行观察比较,探讨苦瓜白粉病抗性与其主要叶片结构指标的关系。结果显示:（1）抗病苦瓜品系叶片的蜡质含量显著高于感病品系,与病情指数呈显著负相关关系,蜡质层是其抵抗和延迟病原菌侵入的一个有力结构屏障。（2）感病品系叶片的气孔和叶背面茸毛数量显著多于抗病品系,且叶背面的气孔及茸毛密度与病情指数呈显著正相关关系,即气孔和茸毛越少越抗病。（3）抗病苦瓜品系的叶片栅栏组织以及海绵组织排列整齐、紧密,而高感品系的叶片组织出现大量孔隙,较难观察到完整细胞。（4）抗病品系叶片厚度、下表皮厚度、栅栏组织厚度、叶片结构紧密度明显高于感病品系,而感病品系的海绵组织厚度、叶片结构疏松度明显高于抗病品系;且苦瓜比叶重与其白粉病抗性关系不大。研究认为,苦瓜叶片蜡质含量、叶背面气孔及茸毛密度可以作为苦瓜白粉病抗性鉴定的参考指标。     

小钻‘白城杨2号’小孢子发生及花粉大小变异

利用醋酸洋红染色压片技术,以温室水培小钻‘白城杨2号’(Populus×xiaozhuanica W.Y.Hsu et Liangcv.‘Baicheng-2’)为材料,对其小孢子发生过程中染色体行为及花粉大小变异进行研究。结果表明:(1)‘白城杨2号’小孢子母细胞减数分裂过程中染色体行为存在一定比例的异常现象,包括终变期单价体、中期Ⅰ染色体提前分离、后期Ⅰ和Ⅱ落后染色体和染色体桥、末期Ⅰ和Ⅱ微核、中期Ⅱ纺锤体定位异常以及胞质分裂异常等,这些异常现象的发生与‘白城杨2号’杂种起源有密切关系。(2)‘白城杨2号’小孢子母细胞减数分裂过程中核仁数目存在动态变化,末期Ⅰ和Ⅱ的子核中最多可看到8个小核仁,可能与杨属树种的多倍体起源有关,其染色体组中可能包含8对具核仁组织者区的染色体。(3)‘白城杨2号’产生空瘪花粉率为3.67%,饱满花粉直径在21.3～52.2μm之间,频率分布总体呈近似高斯分布,0.69%的花粉直径超过37μm,表明其可能产生少量未减数的2n花粉。     

自发性高血压大鼠和Wistar大鼠脑动脉平滑肌细胞膜电流的比较

目的:探讨自发性高血压大鼠(SHR)和Wistar大鼠脑动脉(BA)平滑肌细胞膜电流的异同。方法:应用全细胞膜片钳技术研究SHR和Wistar大鼠BA平滑肌细胞在电流密度、电流组成以及自发性瞬时外向K+电流(STOCs)特性的异同。结果:①当指令电压为0、+20、+40和+60mV时,SHR与Wistar大鼠BA平滑肌细胞间电流密度存在统计学差异(P<0.01)。②SHR与Wistar大鼠BA平滑肌细胞膜电流都对1 mmol/L电压依赖的K+通道(Kv)阻断剂4AP和1 mmol/L大电导Ca2+激活K+通道(BKCa)阻断剂TEA敏感。③SHR的STOCs发放频率和电流幅度都远大于Wistar大鼠。1 mmol/LTEA基本完全阻断STOCs通道电流,而4-AP对STOCs没有影响。结论:SHR和Wistar大鼠脑动脉平滑肌细胞的电流密度存在差异,两种平滑肌细胞外向电流都由BKCa和Kv通道组成。SHR大鼠平滑肌细胞更易诱发由BKCa通道介导的STOCs。     

小儿下呼吸道感染痰培养标本病原菌构成分析

目的了解小儿下呼吸道感染病原菌的分布及对常用抗菌药物的耐药状况。方法对2710例小儿下呼吸道感染患者痰标本进行培养,用VITEK-2Compact微生物鉴定系统鉴定菌种和药敏试验,WHO-NET5．4软件对数据进行分析。结果共分离病原菌675株,革兰阴性杆菌457株,占67．7％,主要为大肠埃希菌、肺炎克雷伯菌;革兰阳性球菌159株,占23．5％,主要为金黄色葡萄球菌、肺炎链球菌;真菌59株,占8．7％,主要为白色假丝酵母菌。结论小儿下呼吸道感染病原菌以革兰阴性杆菌为主,耐药性较为严重,应不断加强耐药性监测,合理使用抗菌药物。     

家蝇溶菌酶MDLZM2基因的克隆、序列分析及原核表达

对家蝇溶菌酶(Musca domestica lysozyme,MDLZM2)基因进行克隆、序列分析,构建原核表达载体并在大肠杆菌中表达。从Gen Bank家蝇基因组中筛选获得MDLZM2基因。以该基因的序列设计引物,进行PCR扩增,测序分析获得该基因完整编码序列。运用生物信息学方法对该基因及其编码蛋白的基本理化性质、信号肽、二级结构、三级结构和保守结构域等方面进行预测和分析。构建p EASY-E1-MDLZM2重组质粒,转化到大肠杆菌BL21(DE3)p Lys S Chemically Competent Cell中进行诱导表达及纯化。结果表明MDLZM2基因ORF全长552 bp,编码183个氨基酸,理论分子量21.2 k Da;等电点为6.13,具有Lysozyme家族的蛋白保守结构域。成功构建重组原核表达p EASY-E1-MDLZM2并诱导表达、纯化重组蛋白,为进一步研究该蛋白的生物学及免疫学活性奠定了基础。     

覆膜支架腔内修复术与药物保守治疗对Stanford B型主动脉夹层动脉瘤患者肝肾功能、炎性因子以及预后的影响

目的:比较覆膜支架腔内修复术与药物保守治疗对Standford B型主动脉夹层动脉瘤的疗效及对患者肝肾功能、炎性因子及预后的影响。方法:选择2012年1月～2014年8月我院收治的Standford B型主动脉夹层动脉瘤患者68例,按照随机数字表法分为对照组与研究组,各34例。对照组入院后采取药物保守治疗,研究组应用覆膜支架腔内修复术治疗。观察两组住院期间死亡率、再次手术或介入率以及治疗前、治疗2周后肝肾功能、血清炎性因子变化。所有患者随访36个月,比较两组患者预后情况。结果:研究组再次手术或介入率为2.94%,低于对照组的22.58%(P0.05)。治疗2周后,研究组丙氨酸转氨酶(ALT)、天门冬氨酸氨基转移酶(AST)、尿素氮(BUN)、肌酐(Cr)、胱抑素C、肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、γ-干扰素(INF-γ)、C反应蛋白(CRP)水平较治疗前降低(P0.05),且研究组低于对照组(P0.05)。两组患者均随访36个月,随访12个月时两组患者生存率分别为100.00%和80.65%,随访36个月时两组患者生存率分别为91.18%和29.03%,经Log Rank分析显示,两组生存率比较差异有统计学意义(P0.05)。结论:覆膜支架腔内修复术治疗Standford B型主动脉夹层动脉瘤的疗效确切,能够改善患者肝肾功能,降低炎症反应,患者近中期随访生存率较高,其效果优于保守治疗。